Arcutis Biotherapeutics announced strong third-quarter 2025 results, reporting revenue of $99.2 million and achieving profitability for the first time, which surpassed analyst expectations. Following ...

Demis Hassabis has spent much of the past decade trying to unlock the secrets of the universe through artificial intelligence ...

Lawrence holds a B.A. in history with a minor in political science from Howard University and is currently pursuing an M.A. in history at Cal Poly. She’s on track to graduate in June 2026 with plans ...

The CISCE has unveiled the 2026 ICSE Class 10 exam timetable, with examinations commencing on February 17 and concluding on ...

CISCE has released the ICSE Class 10 Date Sheet 2026. The exams will be held from February 17 to March 30, 2026. Check the ...

Medicxi, a leading European life sciences venture capital firm, today announced the closing of Medicxi V, a €500 million fund dedicated to building and backing innovative biotechnology companies with ...

Presented new data at the Society of Immunotherapy for Cancer (SITC) annual meeting on CLD-401 protection from immune clearance after systemic administration; data also demonstrates that the platform ...

Protalix BioTherapeutics, Inc. , a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® ...

Menstrual cramps are the only type of pain that we as human beings accept as a normal phenomenon. That makes them far too ...

With the addition of Centro Internacional de Agricultura Tropical (CIAT) in the quarter, Cibus now has 5 LATAM Rice customers as momentum ...

Adjusted EBITDA from continuing operations of $1.2 million for the nine months ended September 30, 2025, compared to a loss of $0.1 million in the year ago period ...

Amounts in the third quarter of 2024 and nine months ended September 30, 2024 represent a downward adjustment of $25.8 million in the price of the Primrose Bio Series A Preferred Shares and a $5.8 ...